The Longevity Supplements Guide: What the Evidence Actually Supports
Longevity supplements are a multibillion-dollar market, and only a small share of what they promise is backed by rigorous human evidence. This guide organizes the supplement landscape by evidence quality - separating the handful with genuine human RCT support from the much larger category of mechanistically plausible but unproven compounds, and the even larger category of marketing dressed as science.
- The most important framework for evaluating longevity supplements is the distinction between mechanistic plausibility (a compound does something interesting in cells or animals) and clinical evidence (a compound demonstrably improves health outcomes in humans in RCTs). The supplement industry routinely conflates these levels of evidence.
- The strongest evidence is narrow: a prescription omega-3 drug, icosapent ethyl, cut cardiovascular events by 25% in high-risk statin users,1 while fish-oil and vitamin D supplements in the VITAL trial did not lower major cardiovascular events or cancer.6,8 Creatine helps older adults build muscle during resistance training.10
- NMN improved muscle insulin sensitivity in a 10-week trial in postmenopausal women with prediabetes, but long-term outcome data for NAD+ boosters are missing.4
- In low-bias trials, beta-carotene, vitamin A and vitamin E supplements increased mortality, making high-dose antioxidants the clearest case of a plausible idea failing in trials.5
- Fix true shortfalls rather than stacking pills: about half of Americans get less magnesium than they need from food;3 vitamin B12 deficiency is common in older adults, and metformin and acid-reducing drugs can lower B12;7 and the 2024 Endocrine Society guideline advises against routine vitamin D testing in the general population.9
The supplement industry has mastered the translation of mechanistic research into product marketing in a way that consistently outpaces the evidence. A compound inhibits mTOR in cell culture - it becomes an "aging reversal" supplement. An animal study shows lifespan extension - it becomes a longevity breakthrough. A human biomarker improves - it is promoted as evidence of clinical benefit without a single outcome RCT ever having been conducted. In our reading, this pattern is common in the longevity supplement space.
This guide organizes the evidence landscape clearly and honestly, using a four-tier framework based on evidence quality.
The Evidence Tiers
Tier 1 - Strong human RCT evidence: Multiple randomized controlled trials in humans demonstrating clinically meaningful benefits on relevant health outcomes. Tier 2 - Promising human data: Human trials showing biological activity and biomarker improvement, but lacking long-term outcome data. Tier 3 - Mechanistically interesting: Strong animal or in vitro data, limited or absent human RCT evidence. Tier 4 - Insufficient evidence: Marketed extensively but lacking meaningful supporting data, or with net-negative evidence from RCTs.
Tier 1: Strongest Human Evidence (for Specific Uses)
Omega-3 fatty acids. The strongest result comes from a prescription drug, not a supplement: in REDUCE-IT, 8,179 statin-treated patients with cardiovascular disease or diabetes and raised triglycerides took 4 g a day of icosapent ethyl, a purified EPA, or placebo. Over a median of 4.9 years, major cardiovascular events occurred in 17.2% versus 22.0% (hazard ratio 0.75).1 Ordinary fish oil at 1 g a day in the VITAL trial of 25,871 adults did not significantly lower major cardiovascular events (hazard ratio 0.92) or invasive cancer (1.03), although heart attacks, a secondary outcome, were 28% lower.6 The omega-3 index measures omega-3 fats in red blood cells; an index of 8% or more was associated with the greatest heart protection and 4% or less with the least.14
Creatine monohydrate. Creatine raises muscle creatine and phosphocreatine, and there is evidence it may counter age-related losses in muscle and strength.2 A 2017 meta-analysis of 22 randomized trials in older adults found that creatine taken during resistance training added 1.37 kg of lean tissue and improved chest press and leg press strength compared with training alone.10 Evidence on memory is more limited: a 2018 review of six small trials found possible improvements in short-term memory and reasoning, with conflicting results for other areas.11
Tier 2: Promising Human Data
Magnesium. Almost half (48%) of the US population consumed less magnesium than required from food in 2005-2006, and low intakes have been linked to type 2 diabetes, metabolic syndrome, raised C-reactive protein and high blood pressure.3 In a 2016 meta-analysis of 25 cohort studies, each extra 100 mg a day of dietary magnesium was linked to an 8% to 13% lower risk of type 2 diabetes.12 For sleep, a 2021 review of three small trials in older adults found people fell asleep about 17 minutes faster, on low to very low quality evidence.13
NMN and NR. In a 10-week randomized trial in postmenopausal women with prediabetes who were overweight or obese, NMN increased muscle insulin sensitivity and insulin signalling compared with placebo.4 What is missing is a long-term trial showing that raising NAD+ with NMN or NR improves outcomes such as heart disease, cognition or physical function.
Berberine is covered in its own article, including what its short-term trials do and do not show.
Tier 3: Mechanistically Interesting, Limited Human Data
Fisetin clears senescent cells in animal studies, but human trial evidence is still thin. Urolithin A, a compound made by gut bacteria from foods such as pomegranate, was tested in a four-month randomized trial of 66 adults aged 65 to 90: 1,000 mg a day improved endurance in hand and leg muscles and lowered some blood markers, including C-reactive protein, but did not significantly improve the main outcomes, six-minute walk distance and muscle energy production.15 Spermidine was tested in the 12-month SmartAge trial in 100 older adults with subjective memory complaints and did not improve memory or biomarkers compared with placebo.16
Tier 4: Not Supported or Potentially Harmful
High-dose antioxidants. A meta-analysis of 68 randomized trials with 232,606 participants found no overall effect on mortality, but in the 47 low-bias trials antioxidant supplements increased mortality by 5%, with beta-carotene (7%), vitamin A (16%) and vitamin E (4%) each linked to higher death rates.5 One hypothesis is that high doses blunt helpful stress signals in the body, but that remains a hypothesis. High-dose antioxidant supplements are not recommended.
Put this research into practice: Supplement Evidence Database · Supplement Interaction Checker · Protocol Cost Calculator
References
- 1Bhatt DL, et al. "Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia." N Engl J Med. 2019;380(1):11-22. PubMed · DOI
- 2Rawson ES, Venezia AC. "Use of creatine in the elderly and evidence for effects on cognitive function in young and old." Amino Acids. 2011;40(5):1349-62. PubMed · DOI
- 3Rosanoff A, et al. "Suboptimal magnesium status in the United States: are the health consequences underestimated?" Nutr Rev. 2012;70(3):153-64. PubMed · DOI
- 4Yoshino M, et al. "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;372(6547):1224-1229. PubMed · DOI
- 5Bjelakovic G, et al. "Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis." JAMA. 2007;297(8):842-57. PubMed · DOI
- 6Manson JE, et al. "Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer." N Engl J Med. 2019;380(1):23-32. PubMed · DOI
- 7National Institutes of Health, Office of Dietary Supplements. "Vitamin B12: Fact Sheet for Health Professionals." ods.od.nih.gov (checked 2026-10-01).
- 8Manson JE, et al. "Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease." N Engl J Med. 2019;380(1):33-44. PubMed · DOI
- 9Demay MB, et al. "Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline." J Clin Endocrinol Metab. 2024;109(8):1907-1947. PubMed · DOI
- 10Chilibeck PD, et al. "Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis." Open Access J Sports Med. 2017;8:213-226. PubMed · DOI
- 11Avgerinos KI, et al. "Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials." Exp Gerontol. 2018;108:166-173. PubMed · DOI
- 12Fang X, et al. "Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies." Nutrients. 2016;8(11). PubMed · DOI
- 13Mah J, Pitre T. "Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis." BMC Complement Med Ther. 2021;21(1):125. PubMed · DOI
- 14Harris WS, Von Schacky C. "The Omega-3 Index: a new risk factor for death from coronary heart disease?" Prev Med. 2004;39(1):212-20. PubMed · DOI
- 15Liu S, et al. "Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial." JAMA Netw Open. 2022;5(1):e2144279. PubMed · DOI
- 16Schwarz C, et al. "Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial." JAMA Netw Open. 2022;5(5):e2213875. PubMed · DOI
